To discourage price hikes on brand-name drugs, the IRA requires manufacturers to pay inflation rebates to Medicare if prices ...

Net sales of $1.62 billion, decrease of 5% Net loss of $712 million and diluted GAAP loss per share of $1.04, including a non-cash goodwill impairment charge of ...

Find all the latest Q2 results 2025 updates of Larsen & Toubro, Coal India, Varun Beverages, CG Power and Industrial ...

China Yuchai International stock's recent pullback may be a buying opportunity amid strong earnings growth and promising 2025 ...

Learn more about whether Alvotech or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alkermes plc or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients ...

Celestica Inc.1 (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today announced its financial results ...